AusperBio is a Biotech company based in San Mateo, California. It has raised $223M in total funding. Latest round: Series B.
AusperBio funding overview
AusperBio is a Biotech company based in San Mateo, California. AusperBio has raised $223M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2025. The round record for AusperBio runs through 2025; nothing later has been disclosed. Investors on record include Qiming Venture Partners, CDH Investments, Genesis Capital, YuanBio Venture Capital, HanKang Capital, Sherpa Capital. 6 distinct backers are named across the disclosed rounds.
AusperBio has raised $223M in total disclosed funding across the rounds on record.
Who has invested in AusperBio?
Qiming Venture Partners, CDH Investments, Genesis Capital, YuanBio Venture Capital, HanKang Capital, Sherpa Capital are named among the investors backing AusperBio.
What was the latest AusperBio funding round?
The most recent disclosed round is a Series B, announced in May 2025.
Where is AusperBio based?
AusperBio is based in San Mateo, California.
What sector does AusperBio operate in?
AusperBio is tracked under Biotech from San Mateo, California, with $223M in disclosed funding.
When did AusperBio last raise?
The last disclosed AusperBio round closed in May 2025 at Series B.
Totals shown for AusperBio aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in San Mateo and the investors behind them below.
